Liwen Deng

Liwen Deng

Auto-generated profile, based on publicly available information

Liwen Deng

Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HLHeinz Läubli
Heinz Läubli
OPOliver M. T. Pearce
Oliver M. T. Pearce
FSFlavio Schwarz
Flavio Schwarz
Shoib Sarwar SiddiquiShoib Sarwar Siddiqui
Shoib Sarwar Siddiqui
LDLingquan Deng
Lingquan Deng
AVAjit Varki
Ajit Varki
Significance: In vitro and in vivo data indicate that hypersialylated tumor cells can engage Siglec-9 on myelomonocytic cells and influence the outcome of the interaction, depending on the stage of tumor growth and the microenvironment. On one hand, engagement of Siglec-9 or Siglec-E by tumor-associated ligands inhibited immunosurveillance and tumor cell killing during establishment of autologous tumors and new metastatic foci. On the other hand, inhibition of tumor-associated macrophages through Siglec-9 led to M1 polarization and reduced growth-promoting inflammation within the tumor microenvironment. This demonstrates a previously unidentified dualistic function of Siglec-9 during cancer progression. A functional polymorphism of Siglec-9 correlated with altered survival of lung cancer patients, suggesting that Siglec-9 might be therapeutically targeted.

1 November 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
HLHeinz Läubli
Heinz Läubli
FAFrederico Alisson-Silva
Frederico Alisson-Silva
MSMichal A. Stanczak
Michal A. Stanczak
Shoib Sarwar SiddiquiShoib Sarwar Siddiqui
Shoib Sarwar Siddiqui
LDLiwen Deng
Liwen Deng
AVAjit Varki
Ajit Varki
Lectin galactoside-binding soluble 3 binding protein (LGALS3BP, also called Mac-2 binding protein) is a heavily glycosylated secreted molecule that has been shown previously to be up-regulated in many cancers and has been implicated in tumor metastatic processes, as well as in other cell adhesion and immune functions. The CD33-related subset of sialic acid-binding immunoglobulin-like lectins (Siglecs) consists of immunomodulatory molecules that have recently been associated with the modulation of immune responses to cancer. Because up-regulation of Siglec ligands in cancer tissue has been observed, the characterization of these cancer-associated ligands that bind to inhibitory CD33-related Siglecs could provide novel targets for cancer immunomodulatory therapy. Here we used affinity chromatography of tumor cell extracts to identify LGALS3BP as a novel sialic acid-dependent ligand for human Siglec-9 and for other immunomodulatory Siglecs, such as Siglec-5 and Siglec-10. In contrast, the mouse homolog Siglec-E binds to murine LGALS3BP with lower affinity. LGALS3BP has been observed to be up-regulated in human colorectal and prostate cancer specimens, particularly in the extracellular matrix. Finally, LGALS3BP was able to inhibit neutrophil activation in a sialic acid- and Siglec-dependent manner. These findings suggest a novel immunoinhibitory function for LGALS3BP that might be important for immune evasion of tumor cells during cancer progression.

12 October 2015 in The EMBO Journal
Verified
Journal Article
Closed access
PDF file
JFJerry J Fong
Jerry J Fong
KSKarthik Sreedhara
Karthik Sreedhara
LDLiwen Deng
Liwen Deng
NVNissi M Varki
Nissi M Varki
TATakashi Angata
Takashi Angata
AVAjit Varki
Ajit Varki

1 November 2014 in Cell Metabolism
Verified
Journal Article
Closed access
PGPhilip L.S.M. Gordts
Philip L.S.M. Gordts
EFErin M. Foley
Erin M. Foley
RLRoger Lawrence
Roger Lawrence
RSRisha Sinha
Risha Sinha
CLCarlos Lameda-Diaz
Carlos Lameda-Diaz
JEJeffrey D. Esko
Jeffrey D. Esko

10 June 2019 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
LDLiwen Deng
Liwen Deng
BSBrady L. Spencer
Brady L. Spencer
JHJoshua A. Holmes
Joshua A. Holmes
RMRong Mu
Rong Mu
SRSara Rego
Sara Rego
KDKelly S. Doran
Kelly S. Doran
Streptococcus agalactiae (Group B Streptococcus, GBS) normally colonizes healthy adults but can cause invasive disease, such as meningitis, in the newborn. To gain access to the central nervous system, GBS must interact with and penetrate brain or meningeal blood vessels; however, the exact mechanisms are still being elucidated. Here, we investigate the contribution of BspC, an antigen I/II family adhesin, to the pathogenesis of GBS meningitis. Disruption of the bspC gene reduced GBS adherence to human cerebral microvascular endothelial cells (hCMEC), while heterologous expression of BspC in non-adherent Lactococcus lactis conferred bacterial attachment. In a murine model of hematogenous meningitis, mice infected with ΔbspC mutants exhibited lower mortality as well as decreased brain bacterial counts and inflammatory infiltrate compared to mice infected with WT GBS strains. Further, BspC was both necessary and sufficient to induce neutrophil chemokine expression. We determined that BspC interacts with the host cytoskeleton component vimentin, and confirmed this interaction using a bacterial two-hybrid assay, microscale thermophoresis, immunofluorescent staining, and imaging flow cytometry. Vimentin null mice were protected from WT GBS infection and also exhibited less inflammatory cytokine production in brain tissue. These results suggest that BspC and the vimentin interaction is critical for the pathogenesis of GBS meningitis. Group B Streptococcus (GBS) typically colonizes healthy adults but can cause severe disease in immune compromised individuals, including newborns. Despite wide-spread intrapartum antibiotic prophylaxis given to pregnant women, GBS remains a leading cause of neonatal meningitis. To cause meningitis, GBS must interact with and penetrate the blood-brain barrier (BBB), which separates bacteria and immune cells in the blood from the brain. In order to develop targeted therapies to treat GBS meningitis, it is important to understand the mechanisms of BBB crossing. Here, we describe the role of the GBS surface factor, BspC, in promoting meningitis and discover the host ligand for BspC, vimentin, which is an intermediate filament protein that is constitutively expressed by endothelial cells. We determined that BspC interacts with the C-terminal domain of cell-surface vimentin to promote bacterial attachment to brain endothelial cells and that purified BspC protein can induce immune signaling pathways. In a mouse model of hematogenous meningitis, we observed that a GBS mutant lacking BspC was less virulent compared to WT GBS and resulted in less inflammatory disease. We also observed that mice lacking vimentin were protected from GBS infection. These results reveal the importance of the BspC-vimentin interaction in the progression of GBS meningitis disease.

1 November 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
FMFang Ma
Fang Ma
DWDiana Wu
Diana Wu
LDLiwen Deng
Liwen Deng
PSPatrick Secrest
Patrick Secrest
JZJune Zhao
June Zhao
PGPascal Gagneux
Pascal Gagneux
Sialic acids (Sias) mediate many biological functions, including molecular recognition during development, immune response, and fertilization. A Sia-rich glycocalyx coats the surface of sperm, allowing them to survive as allogeneic cells in the female reproductive tract despite female immunity. During capacitation, sperm lose a fraction of their Sias. We quantified shed Sia monosaccharides released from capacitated sperm and measured sperm sialidase activity. We report the presence of two sialidases (neuraminidases Neu1 and Neu3) on mammalian sperm. These are themselves shed from sperm during capacitation. Inhibiting sialidase activity interferes with sperm binding to the zona pellucida of the ovum. A survey of human sperm samples for the presence of sialidases NEU1 and NEU3 identified a lack of one or both sialidases in sperm of some male idiopathic infertility cases. The results contribute new insights into the dynamic remodeling of the sperm glycocalyx prior to fertilization.